Latest Biotech News

Sophia Genetics rolled out a Digital Twins module inside its Sophia DDM cloud platform to simulate disease trajectories, treatment responses and survival outcomes using multimodal clinical,...

Lonza received Swissmedic approval and a GMP license for a new aseptic drug‑product filling line in Stein (Switzerland), adding high‑containment capabilities for highly potent biologics including...

Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, reported an ultra‑rapid whole‑genome sequencing workflow that produced variant calls in...

Kite Pharma (Gilead) struck a development and licensing agreement with China’s Pregene Biopharma to accelerate next‑generation in vivo CAR‑T therapies, committing up to $1.64 billion and an...

Praxis Precision Medicines reported that its oral T‑type calcium channel inhibitor ulixacaltamide met primary and key secondary endpoints in two pivotal Phase 3 trials for essential tremor. The...

The marketplace responded immediately to Praxis’ Phase 3 success: shares more than tripled intraday after the company disclosed positive topline results and plans for an NDA submission. Company...

Novo Nordisk licensed global rights to Omeros’ zaltenibart, a MASP‑3 blocking antibody targeting complement‑mediated rare blood and kidney disorders, in a deal that could reach $2.1 billion plus...

Aicuris Anti‑Infective Cures reported positive Phase 3 results for pritelivir in healing refractory herpes simplex virus lesions in immunocompromised patients and said it will prepare a U.S. NDA...

Tubulis secured a $361 million Series C to accelerate clinical development of its antibody‑drug conjugate (ADC) pipeline and expand manufacturing and translational capabilities. The German...

French antibody developer Adcytherix closed a €105 million (about $122 million) Series A to take its lead ADC into first‑in‑human studies next year. The funding will support IND‑enabling work and...

Researchers published DeepSomatic, a deep‑learning somatic small‑variant caller designed to work across short‑ and long‑read sequencing technologies, alongside a set of public benchmarking...

A companion Nature Biotechnology report details methods and public datasets aimed at improving somatic variant calling with long‑read technologies and shows how combining long‑ and short‑read data...

Tempus AI entered a multi‑year collaboration with Whitehawk Therapeutics to apply Tempus’ de‑identified multimodal real‑world dataset to Whitehawk’s ADC development programs. The partnership will...

Plasmidsaurus unveiled a new ultrafast RNA‑seq service tailored for Illumina short‑read applications, offering rapid transcriptomics deliverables—crude cell preps to analyzed results in as fast as...

Plasmidsaurus said the new RNA‑seq offering complements recent launches—overnight microbiome amplicon sequencing and fast AAV genome services—and noted expansion into multiple global labs...

Lonza received Swissmedic approval and a GMP license for a new aseptic drug‑product filling line in Stein, Switzerland, optimized for highly potent biologics including ADCs. The line adds liquid...

A global phase 3 FLAURA2 trial reported a statistically significant overall survival benefit when osimertinib was combined with platinum–pemetrexed chemotherapy versus osimertinib alone in...

Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, demonstrated an ultra‑rapid whole‑genome sequencing (WGS) workflow that produced variant calls...

Two companion Nature Biotechnology reports introduce DeepSomatic, a deep‑learning somatic small‑variant caller designed to work across short‑ and long‑read sequencing platforms, and a set of...

GeneDx piloted Illumina’s Constellation mapped‑read technology on NovaSeq X Plus instruments to detect variants that evade standard short‑read methods. The early access pilot, presented at ASHG,...